DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5613f4/emerging_markets_f) has announced the addition of the "Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials" report to their offering.
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials that provides key data, information and analysis of the major trends and issues affecting the Clinical Trial market in India. The report provides a comprehensive insight of reasons for outsourcing clinical trials to India and the key services provided by the CROs of India. The report also provides a detailed analysis of the Indian market in terms of its size, and major service offerings of the CROs in India. The report also discusses the factors that are driving the clinical trial market in India and China. The report delves into the key regulations, especially with respect to the clinical trial approval process for molecules discovered outside India as well as within India, and how the regulations have benefited the CROs. It also provides an insight into the government support initiatives in India to encourage the clinical trials. The report also provides key alliances and acquisitions between the western CROs and the local CROs of India, and the key trends emerging out of such partnerships. The report also looks into the major challenges that can restrict the growth of the clinical trials market in India.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts.
Rising Financial and Regulatory Pressures on Western Pharma Will Continue to Drive the Clinical Trial Market Growth in India
The pharmaceutical industries of the US and Europe are facing severe financial constraints since the past few years, which are expected to worsen in the coming years. With pressures such as increasing cost of introducing an NME to reach more than $3 billion in 2008, tightening regulatory pressures resulting in fewer FDA approvals, blockbuster drugs worth more than $100 billion set to expire by 2014 and drying pipelines of the pharmaceutical industry, cost cutting pressures are mounting on pharmaceutical companies, especially big pharma. These pressures are expected to drive these companies towards low-cost countries such as India to perform their R&D activities, one of their major expenses.
India, over the last decade, has developed significant capabilities in clinical trials, along with certain capabilities in project management and data management. India is able to provide significant cost savings in the range of 50-60% for clinical trials. With discovery research occupying close to one-third of the R&D expenditure for the western pharmaceutical industry, outsourcing to low-cost countries is logical. As the financial and regulatory pressures grow on the US and European pharmaceutical industry, it is expected to further propel the growth in the Indian clinical trial market.
Scope
The scope of this report includes:
- Annualized data from 2001 to 2009, forecast forward to 2016.
- Market characterization, including market size
- Analysis of the leading therapeutic areas under clinical research in India
- Key drivers and barriers that have a significant impact on the clinical trials market.
- Competitive benchmarking of leading companies.
- Key M&A activities and strategic partnership deals that have taken place in 2009
Reasons to buy
The report will enhance your decision making capability.
It will allow you to
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.
- Device a more tailored country strategy through the understanding of key drivers and barriers in conducting clinical trial in the country.
- Develop key strategic initiatives by understanding the key focus of clinical research of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Key Topics Covered:
1 Table of Contents
2 Emerging Market for Clinical Trials - India - Introduction
3 Emerging Market for Clinical Trials - India - Overview
4 Emerging Market for Clinical Trials India - Clinical Trial Trends
5 Emerging Market for Clinical Trials India - Market Environment Characterization
6 Emerging Market for Clinical Trials India - Regulatory Landscape
7 Emerging Market for Clinical Trials India - CRO Landscape
8 Emerging Market for Clinical Trials India - Appendix
For more information visit http://www.researchandmarkets.com/research/5613f4/emerging_markets_f